Archive




Volume 5, Issue 3, June 2017, Page: 47-52
Comprehensive Treatment of Advanced Liver Cancer Complicated with Upper Gastrointestinal Bleeding in Multidisciplinary Team Model: A Case Report
Liuming Lin, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China
Mingrong Cao, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China
Qiang Li, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China
Zhilong Liu, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China
Received: Apr. 20, 2017;       Accepted: May 4, 2017;       Published: May 31, 2017
DOI: 10.11648/j.js.20170503.13      View  2366      Downloads  129
Abstract
A 44-year-old male was presented to emergency department because of repeated abdominal distension for 1 month, melena for 1 day and hematemesis for 4 hours. After examination, he was diagnosed with esophageal varices (III degree) and hemorrhage, primary massive hepatocellular carcinoma (cT3aN1Mx) and hepatitis B cirrhosis. In collaboration with the MDT team, this patient received a comprehensive treatment for up to 19 months which included surgical devascularization and cryoablation for liver cancer, TACE, SBRT, molecular targeted therapy, Chinese medicine treatment, antiviral therapy and so on. The latest review showed that liver cancer had distant metastasis, but the quality of life was still good. It seems that the comprehensive treatment of MDT is helpful for patients with HCC to improve the quality of life.
Keywords
Hepatocellular Carcinoma, Comprehensive Treatment, Multi-disciplinary Team
To cite this article
Liuming Lin, Mingrong Cao, Qiang Li, Zhilong Liu, Comprehensive Treatment of Advanced Liver Cancer Complicated with Upper Gastrointestinal Bleeding in Multidisciplinary Team Model: A Case Report, Journal of Surgery. Vol. 5, No. 3, 2017, pp. 47-52. doi: 10.11648/j.js.20170503.13
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Balogh J, Victor D, Asham E H, et al. Hepatocellular carcinoma: a review [J]. Journal of Hepatocellular Carcinoma, 2016, 3: 41-53.
[2]
Shen Q, Xue H, Jiang Q. Surgical treatment of primary liver cancer complicated with portal hypertension [J]. Journal of Practical Diagnosis & Therapy, 2007.
[3]
Ding Z H, Mu Y, Zhang L, et al. Radiofrequency ablation combined with devascularization in treati ng primary liver cancer with portal hypertension: An analysis of 69 cases, 2013, 33 (11): 967-969.
[4]
Xu K C, Niu L Z. Cryosurgery for hepatocellular carcinoma [J]. World Chinese Journal of Digestology, 2008, 16 (3): 229-235.
[5]
Wang Z L, Zhang Y W. Progress on cellular immune function after the cryosurgical treatment of various cancers [J]. Chinese Journal of Interventional Imaging & Therapy, 2012, 9 (7): 556-559.
[6]
Gao J L. [Prospective randomized controlled study on advanced primary hepatic cancer treated by ganfule prescription] [J]. China Journal of Chinese Materia Medica, 2014, 39 (12): 2367.
[7]
Wu H, Hospital A N, University N M. Huaier Granules Combined with Chemoembolization in Treating Primary Liver Cancer in 96 Cases [J]. China Pharmaceuticals, 2014.
[8]
Jang J W. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy [J]. World Journal of Gastroenterology Wjg, 2014, 20 (24): 7675.
[9]
Ishikawa T. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma [J]. World Journal of Gastroenterology, 2013, 19 (47): 8861-8866.
[10]
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. american association for the study of liver diseases (AASLD) practice guideline [J]. 2011, 53: 1020-1035.
[11]
Omata M, Lesmana L A, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma [J]. Hepatology International, 2010, 4 (2): 439.
[12]
Meng M B, Cui Y L, Lu Y, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. [J]. Radiotherapy & Oncology, 2009, 92 (2): 184-194.
[13]
Chang T T, Sawhney R, Monto A, et al. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival [J]. HPB, 2008, 10 (6): 405-411.
[14]
Yopp A C, Mansour J C, Beg M S. Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome [J]. Annals of Surgical Oncology, 2014, 21 (4): 1287-95.
Browse journals by subject